94 related articles for article (PubMed ID: 10519382)
1. Modulation of receptor phosphorylation contributes to activation of peroxisome proliferator activated receptor alpha by dehydroepiandrosterone and other peroxisome proliferators.
Tamasi V; Miller KK; Ripp SL; Vila E; Geoghagen TE; Prough RA
Mol Pharmacol; 2008 Mar; 73(3):968-76. PubMed ID: 18079279
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor alpha-dependent induction of cell surface antigen Ly-6D gene in the mouse liver.
Dadras SS; Cook WS; Yeldandi AV; Cao WQ; Rao MS; Wang Z; Reddy JK
Gene Expr; 2001; 9(4-5):173-81. PubMed ID: 11444527
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid represses CYP7A1 expression in human hepatocytes and HepG2 cells by FXR/RXR-dependent and independent mechanisms.
Cai SY; He H; Nguyen T; Mennone A; Boyer JL
J Lipid Res; 2010 Aug; 51(8):2265-74. PubMed ID: 20338915
[TBL] [Abstract][Full Text] [Related]
4. Transactivation of the peroxisome proliferator-activated receptor is differentially modulated by hepatocyte nuclear factor-4.
Winrow CJ; Marcus SL; Miyata KS; Zhang B; Capone JP; Rachubinski RA
Gene Expr; 1994; 4(1-2):53-62. PubMed ID: 7841788
[TBL] [Abstract][Full Text] [Related]
5. Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha -interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator.
Surapureddi S; Yu S; Bu H; Hashimoto T; Yeldandi AV; Kashireddy P; Cherkaoui-Malki M; Qi C; Zhu YJ; Rao MS; Reddy JK
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11836-41. PubMed ID: 12189208
[TBL] [Abstract][Full Text] [Related]
6. In vivo activation of PPAR target genes by RXR homodimers.
IJpenberg A; Tan NS; Gelman L; Kersten S; Seydoux J; Xu J; Metzger D; Canaple L; Chambon P; Wahli W; Desvergne B
EMBO J; 2004 May; 23(10):2083-91. PubMed ID: 15103326
[TBL] [Abstract][Full Text] [Related]
7. PPAR alpha is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue.
Lee Y; Yu X; Gonzales F; Mangelsdorf DJ; Wang MY; Richardson C; Witters LA; Unger RH
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11848-53. PubMed ID: 12195019
[TBL] [Abstract][Full Text] [Related]
8. Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells.
Zhou YT; Shimabukuro M; Wang MY; Lee Y; Higa M; Milburn JL; Newgard CB; Unger RH
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8898-903. PubMed ID: 9671776
[TBL] [Abstract][Full Text] [Related]
9. A reverse translational study of PPAR-α agonist efficacy in human and rodent models relevant to alcohol use disorder.
Mason BJ; Estey D; Roberts A; de Guglielmo G; George O; Light J; Stoolmiller M; Quello S; Skinner M; Shadan F; Begovic A; Kyle MC; Harris RA
Neurobiol Stress; 2024 Mar; 29():100604. PubMed ID: 38292518
[TBL] [Abstract][Full Text] [Related]
10. Application research on PPARα-transgenic mice in preclinical safety evaluation of gemfibrozil.
Li Y; Mao H; Xu Y; Li X; Pan L; Wu X; Li Y; Li Y; He J
Toxicol Res (Camb); 2017 Jan; 6(1):98-104. PubMed ID: 30090481
[TBL] [Abstract][Full Text] [Related]
11. The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions.
Corton JC; Peters JM; Klaunig JE
Arch Toxicol; 2018 Jan; 92(1):83-119. PubMed ID: 29197930
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome Proliferator-Activated Receptor -β/δ, -γ Agonists and Resveratrol Modulate Hypoxia Induced Changes in Nuclear Receptor Activators of Muscle Oxidative Metabolism.
Regnault TR; Zhao L; Chiu JS; Gottheil SK; Foran A; Yee SP
PPAR Res; 2010; 2010():129173. PubMed ID: 21113404
[TBL] [Abstract][Full Text] [Related]
13. The PPAR alpha-humanized mouse: a model to investigate species differences in liver toxicity mediated by PPAR alpha.
Yang Q; Nagano T; Shah Y; Cheung C; Ito S; Gonzalez FJ
Toxicol Sci; 2008 Jan; 101(1):132-9. PubMed ID: 17690133
[TBL] [Abstract][Full Text] [Related]
14. Addition of peroxisome proliferator-activated receptor alpha to guinea pig hepatocytes confers increased responsiveness to peroxisome proliferators.
Macdonald N; Holden PR; Roberts RA
Cancer Res; 1999 Oct; 59(19):4776-80. PubMed ID: 10519382
[TBL] [Abstract][Full Text] [Related]
15. Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression.
Hasmall SC; James NH; Macdonald N; Soames AR; Roberts RA
Arch Toxicol; 2000 Apr; 74(2):85-91. PubMed ID: 10839475
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha).
Roberts RA; James NH; Woodyatt NJ; Macdonald N; Tugwood JD
Carcinogenesis; 1998 Jan; 19(1):43-8. PubMed ID: 9472691
[TBL] [Abstract][Full Text] [Related]
17. Mouse hepatocyte response to peroxisome proliferators: dependency on hepatic nonparenchymal cells and peroxisome proliferator activated receptor alpha (PPARalpha).
Hasmall S; James N; Hedley K; Olsen K; Roberts R
Arch Toxicol; 2001 Aug; 75(6):357-61. PubMed ID: 11570693
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptors, coactivators, and downstream targets.
Qi C; Zhu Y; Reddy JK
Cell Biochem Biophys; 2000; 32 Spring():187-204. PubMed ID: 11330046
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor (PPAR) alpha-regulated growth responses and their importance to hepatocarcinogenesis.
James NH; Gill JH; Brindle R; Woodyatt NJ; Macdonald N; Rolfe M; Hasmall SC; Tugwood JD; Holden PR; Roberts RA
Toxicol Lett; 1998 Dec; 102-103():91-6. PubMed ID: 10022238
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
